ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer | EMBO Molecular Medicine
Molecules | Free Full-Text | Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Tumor necrosis factor Alpha Converting Enzyme (TACE) aka ADAM17 cleaves... | Download Scientific Diagram
Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice | Signal Transduction and Targeted Therapy
ADAM17: a molecular switch to control inflammation and tissue regeneration: Trends in Immunology
ADAM17 | Arteriosclerosis, Thrombosis, and Vascular Biology
Role of ADAM17 in kidney disease | American Journal of Physiology-Renal Physiology
JCM | Free Full-Text | ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
Aderbasib is a Highly Potent and Orally Active Inhibitor of ADAM10 and ADAM17 - Network of Cancer Research
Frontiers | Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis
JCI Insight - ADAM17 substrate release in proximal tubule drives kidney fibrosis
Control of ADAM17 activity by regulation of its cellular localisation | Scientific Reports
Contribution of ADAM17 and related ADAMs in cardiovascular diseases | SpringerLink
Contribution of ADAM17 and related ADAMs in cardiovascular diseases | SpringerLink
The role of ADAM17 during liver damage
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | EMBO reports
Role of ADAM17 in kidney disease | American Journal of Physiology-Renal Physiology
ADAM17 Recombinant Monoclonal Antibody (3H46L1) (703077)
The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports
ADAM17 mediates cardiovascular diseases via ectodomain shedding. A... | Download Scientific Diagram
Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice | Arteriosclerosis, Thrombosis, and Vascular Biology
The role of ADAM17 during liver damage
